!function(){"use strict";var t={d:function(e,n){for(var i in n)t.o(n,i)&&!t.o(e,i)&&Object.defineProperty(e,i,{enumerable:!0,get:n[i]})},o:function(t,e){return Object.prototype.hasOwnProperty.call(t,e)},r:function(t){"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(t,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(t,"__esModule",{value:!0})}},e={};t.r(e),t.d(e,{__useActiveDocument:function(){return u},__useActiveDocumentActions:function(){return y},__useHostDocument:function(){return l},__useNavigateToDocument:function(){return S},slice:function(){return m}});var n=window.elementorV2.editor,i=window.elementorV2.store,o=window.React,a=window.wp.i18n,s=window.elementorV2.editorV1Adapters,r=t=>t.documents.entities,c=(0,i.__createSelector)(r,(t=>t.documents.activeId),((t,e)=>e&&t[e]?t[e]:null)),d=(0,i.__createSelector)(r,(t=>t.documents.hostId),((t,e)=>e&&t[e]?t[e]:null));function u(){return(0,i.__useSelector)(c)}function l(){return(0,i.__useSelector)(d)}function _(t){return!(!t.activeId||!t.entities[t.activeId])}var m=(0,i.__createSlice)({name:"documents",initialState:{entities:{},activeId:null,hostId:null},reducers:{init(t,{payload:e}){t.entities=e.entities,t.hostId=e.hostId,t.activeId=e.activeId},activateDocument(t,e){t.entities[e.payload.id]=e.payload,t.activeId=e.payload.id},setAsHost(t,e){t.hostId=e.payload},updateActiveDocument(t,e){_(t)&&(t.entities[t.activeId]={...t.entities[t.activeId],...e.payload})},startSaving(t){_(t)&&(t.entities[t.activeId].isSaving=!0)},endSaving(t,e){_(t)&&(t.entities[t.activeId]={...e.payload,isSaving:!1})},startSavingDraft:t=>{_(t)&&(t.entities[t.activeId].isSavingDraft=!0)},endSavingDraft(t,e){_(t)&&(t.entities[t.activeId]={...e.payload,isSavingDraft:!1})},markAsDirty(t){_(t)&&(t.entities[t.activeId].isDirty=!0)},markAsPristine(t){_(t)&&(t.entities[t.activeId].isDirty=!1)}}});function v(){const t=window.elementor?.documents;if(!t)throw new Error("Elementor Editor V1 documents manager not found");return t}function p(t){switch(window.elementor?.getPreferences?.("exit_to")||"this_post"){case"dashboard":return t.config.urls.main_dashboard;case"all_posts":return t.config.urls.all_post_type;default:return t.config.urls.exit_to_dashboard}}function f(t){return t?.config?.panel?.show_copy_and_share??!1}function g(t){return t.config.urls.permalink??""}function h(t){const e=t.config.revisions.current_id!==t.id,n=p(t);return{id:t.id,title:t.container.settings.get("post_title"),type:{value:t.config.type,label:t.config.panel.title},status:{value:t.config.status.value,label:t.config.status.label},links:{permalink:g(t),platformEdit:n},isDirty:t.editor.isChanged||e,isSaving:t.editor.isSaving,isSavingDraft:!1,permissions:{allowAddingWidgets:t.config.panel?.allow_adding_widgets??!0,showCopyAndShare:f(t)},userCan:{publish:t.config.user.can_publish}}}function w(t,e){let n;return(...i)=>{clearTimeout(n),n=setTimeout((()=>{t(...i)}),e)}}function y(){const t=u(),e=t?.links?.permalink??"";return{save:(0,o.useCallback)((()=>(0,s.__privateRunCommand)("document/save/default")),[]),saveDraft:(0,o.useCallback)((()=>(0,s.__privateRunCommand)("document/save/draft")),[]),saveTemplate:(0,o.useCallback)((()=>(0,s.__privateOpenRoute)("library/save-template")),[]),copyAndShare:(0,o.useCallback)((()=>{navigator.clipboard.writeText(e)}),[e])}}function S(){return(0,o.useCallback)((async t=>{await(0,s.__privateRunCommand)("editor/documents/switch",{id:t,setAsInitial:!0});const e=new URL(window.location.href);e.searchParams.set("post",t.toString()),e.searchParams.delete("active-document"),history.replaceState({},"",e)}),[])}(0,i.__registerSlice)(m),function(){const{init:t}=m.actions;(0,s.__privateListenTo)((0,s.v1ReadyEvent)(),(()=>{const e=v(),n=Object.entries(e.documents).reduce(((t,[e,n])=>(t[e]=h(n),t)),{});(0,i.__dispatch)(t({entities:n,hostId:e.getInitialId(),activeId:e.getCurrentId()}))}))}(),function(){const{activateDocument:t,setAsHost:e}=m.actions;(0,s.__privateListenTo)((0,s.commandEndEvent)("editor/documents/open"),(()=>{const n=v(),o=h(n.getCurrent());(0,i.__dispatch)(t(o)),n.getInitialId()===o.id&&(0,i.__dispatch)(e(o.id))}))}(),function(){const{startSaving:t,endSaving:e,startSavingDraft:n,endSavingDraft:o}=m.actions,a=t=>{const e=t;return"autosave"===e.args?.status};(0,s.__privateListenTo)((0,s.commandStartEvent)("document/save/save"),(e=>{a(e)?(0,i.__dispatch)(n()):(0,i.__dispatch)(t())})),(0,s.__privateListenTo)((0,s.commandEndEvent)("document/save/save"),(t=>{const n=h(v().getCurrent());a(t)?(0,i.__dispatch)(o(n)):(0,i.__dispatch)(e(n))}))}(),function(){const{updateActiveDocument:t}=m.actions,e=w((e=>{const n=e;if(!("post_title"in n.args?.settings))return;const o=v().getCurrent().container.settings.get("post_title");(0,i.__dispatch)(t({title:o}))}),400);(0,s.__privateListenTo)((0,s.commandEndEvent)("document/elements/settings"),e)}(),function(){const{markAsDirty:t,markAsPristine:e}=m.actions;(0,s.__privateListenTo)((0,s.commandEndEvent)("document/save/set-is-modified"),(()=>{v().getCurrent().editor.isChanged?(0,i.__dispatch)(t()):(0,i.__dispatch)(e())}))}(),function(){const{updateActiveDocument:t}=m.actions,e=w((e=>{const n=e;if(!("exit_to"in n.args?.settings))return;const o=v().getCurrent(),a=p(o),s=g(o);(0,i.__dispatch)(t({links:{platformEdit:a,permalink:s}}))}),400);(0,s.__privateListenTo)((0,s.commandEndEvent)("document/elements/settings"),e)}(),(0,n.injectIntoLogic)({id:"documents-hooks",component:function(){return function(){const t=u(),e=l(),n=t&&"kit"!==t.type.value?t:e;(0,o.useEffect)((()=>{if(void 0===n?.title)return;const t=(0,a.__)('Edit "%s" with Elementor',"elementor").replace("%s",n.title);window.document.title=t}),[n?.title])}(),null}}),(window.elementorV2=window.elementorV2||{}).editorDocuments=e}();
Efectos de Femara en el Tratamiento del Cáncer – Euro Star
Femara es un medicamento utilizado principalmente en el tratamiento del cáncer de mama en mujeres postmenopáusicas. Su principio activo, letrozol, actúa como un inhibidor de la aromatasa, bloqueando la producción de estrógenos en el organismo. Esto es crucial ya que algunos tipos de cáncer de mama son hormonodependientes y pueden crecer en respuesta a esta hormona.
Die neuesten Informationen über Femara finden Sie auf der Website des führenden Sportpharmazie-Shops in Deutschland. Beeilen Sie sich mit dem Kauf!
Efectos Secundarios de Femara
Como cualquier medicamento, Femara puede provocar una serie de efectos secundarios. Algunos de los más comunes incluyen:
Oleadas de calor
Fatiga
Dificultades para dormir
Aumento de peso
Dolor en las articulaciones o músculos
Sequedad vaginal
Consideraciones Importantes
Es fundamental que las pacientes hablen con su médico acerca de los posibles efectos de Femara y cualquier preocupación que puedan tener. El médico podrá proporcionar información detallada y ayudará a gestionar los efectos secundarios si se presentan. La supervisión médica es esencial durante todo el tratamiento para asegurar la mejor respuesta terapéutica y minimizar riesgos.
Conclusión
Femara ha demostrado ser eficaz en el tratamiento de ciertos tipos de cáncer de mama, pero es importante estar informado sobre sus efectos y seguir las recomendaciones médicas para un manejo adecuado del tratamiento.
What's your reaction? 0 cool 0 wtf 0 love 0 lol
Post rating: 0 from 5 (according 0 votes )